Rizwana F Sproule has sold KITE and made no open-market buys since Jan 2016
VP Regulatory Affairs at Kite Pharma, Inc.
SEC CIK 0001609644 · Filings on SEC.gov ↗
$0Bought
$1.3MSold
NoneLast buy
Every filing
3 filings since Jan 2016, newest first
Filings come from SEC EDGAR. Not investment advice.